Xenotransplantation of hDAF transgenic pig hearts;Xenotransplantation hDAF-transgener Schweineherzen

Zentralblatt fur Chirurgie

Volumn 124, Issue 7, 1999, Pages 604-608

  Schmoeckel, M ^a,c   Cozzi, E ^a   Chavez, G ^a   Dunning, J J ^b   Wallwork, J ^b   White, D J G ^a  

^a Imutran Ltd   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Heterotopic and orthotopic heart transplantation; Human decay accelerating factor; Primates; Transgenic pigs; Xenotransplantation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; STEROID;

ANIMAL TISSUE; ARTICLE; BABOON; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MONKEY; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL TIME; TRANSGENIC ANIMAL; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; DRUG THERAPY, COMBINATION; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACACA FASCICULARIS; MYOCARDIUM; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HETEROTOPIC;

EID: 0032815285     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bellgrau D, Gold D, Selawry H (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
2. Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340: 741-745
3. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS (1997) Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63: 149-155
4. Cozzi E, Tucker AW, Langford GA, Pino-Chavez G, Wright L, O'Connell MJ, Young VK, Lancaster R, McLaughlin M, Hunt K, Bordin MC, White DJG (1997) Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 64: 1383-1392
5. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM (1994) Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261-3282
6. Lower RR, Stofer RC, Shumway NE (1960) Studies on the orthotopic homotransplantation of the canine heart. Surg Forum 11: 18-21
7. Morris PJ (1997) Pig transplants postponed until we know more about graft rejection, physiology, and infectivity. Br Med J 314: 242
8. Ono K, Lindsey ES (1969) Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57: 225-229
9. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH (1991) Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52: 214-220
10. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC, Collins BH, Levin JL, Mault JR, Heinle JS, Ibrahim S, Rudolph AR, Baldwin WM, Sanfilippo F (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57: 363-370
11. Schmoeckel M, Nollert G, Shahmohammadi M, Young VK, Chavez G, Kasper-König W, White DJG, Müller-Höcker J, Arendt RM, Wilbert-Lampen U, Hammer C, Reichart B (1996) Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 62: 729-734
12. Schmoeckel M, Nollert G, Shahmohammadi M, Müller-Höcker J, Young VK, Kasper-König W, White DJG, Hammer C, Reichart B (1997) Transgenic human decay accelerating factor makes normal pigs function as a concordant species. J Heart Lung Transplant 16: 758-764
13. Schmoeckel M, Wallwork J, White DJG (1999) Cardiac xenograft organs from transgenic pigs. In: Franco KL, Verrier ED (Hrsg) Advanced therapy in cardiac surgery, S 520-526. Hamilton London, St. Louis: Decker
14. Seino K-I, Kayagaki N, Tsukada N, Fukao K, Yagita H, Okumura K (1997) Transplantation of CD95 ligand-expressing grafts. Transplantation 64: 1050-1054
15. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS (1996) Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 93: 7190-7195
16. Stark JH, Smit JA, Gridelli B (1994) Sensitivity of baboon lymphocytes to cyclosporin A and FK 506: relative resistance of allo-activated cells to CyA. Transplant Int 7: 372-378
17. van den Berg CW, Morgan BP (1994) Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 152: 4095-4101
18. van den Berg CW, Pérez de la Lastra JM, Llanes D, Morgan BP (1997) Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP). J Immunol 158: 1703-1709
19. White DJG (1996) hDAF transgenic pig organs: are they concordant for human transplantation? Xeno 4: 50-54